Literature DB >> 27661448

Two missense mutations in SALL4 in a patient with microphthalmia, coloboma, and optic nerve hypoplasia.

E Ullah1,2, D Wu1, L Madireddy3, R Lao4, P Ling-Fung Tang4, E Wan4, T Bardakjian5, S Kopinsky5, P-Y Kwok4, A Schneider5, S Baranzini3, M Ansar2, A Slavotinek1.   

Abstract

To investigate the genetic etiology of anophthalmia and microphthalmia, we used exome sequencing in a Caucasian female with unilateral microphthalmia and coloboma, bilateral optic nerve hypoplasia, ventricular and atrial septal defects, and growth delays. We found two sequence variants in SALL4 - c.[575C>A], predicting p.(Ala192Glu), that was paternally inherited, and c.[2053G>C], predicting p.(Asp685His), that was maternally inherited. Haploinsufficiency for SALL4 due to nonsense or frameshift mutations has been associated with acro-renal ocular syndrome that is characterized by eye defects including Duane anomaly and coloboma, in addition to radial ray malformations and renal abnormalities. Our report is the first description of structural eye defects associated with two missense variants in SALL4 inherited in trans; the absence of reported findings in both parents suggests that both sequence variants are hypomorphic mutations and that both are needed for the ocular phenotype. SALL4 is expressed in the developing lens and regulates BMP4, leading us to speculate that altered BMP4 expression was responsible for the eye defects, but we could not demonstrate altered BMP4 expression in vitro after using small interfering RNAs (siRNAs) to reduce SALL4 expression. We conclude that SALL4 hypomorphic variants may influence eye development.

Entities:  

Keywords:  Anophthalmia; BMP4; SALL4; coloboma; microphthalmia

Mesh:

Substances:

Year:  2016        PMID: 27661448      PMCID: PMC6238016          DOI: 10.1080/13816810.2016.1217550

Source DB:  PubMed          Journal:  Ophthalmic Genet        ISSN: 1381-6810            Impact factor:   1.803


  38 in total

Review 1.  Eye development genes and known syndromes.

Authors:  Anne M Slavotinek
Journal:  Mol Genet Metab       Date:  2011-09-29       Impact factor: 4.797

2.  SALL4 mutations in Okihiro syndrome (Duane-radial ray syndrome), acro-renal-ocular syndrome, and related disorders.

Authors:  Jürgen Kohlhase; David Chitayat; Dieter Kotzot; Serdar Ceylaner; Ursula G Froster; Sigrun Fuchs; Tara Montgomery; Bernd Rösler
Journal:  Hum Mutat       Date:  2005-09       Impact factor: 4.878

3.  Further delineation of the acro-renal-ocular syndrome.

Authors:  C M Aalfs; M J van Schooneveld; E M van Keulen; R C Hennekam
Journal:  Am J Med Genet       Date:  1996-03-29

4.  Immunoexpression of SALL4 in Wilms tumors and developing kidney.

Authors:  Jeremy Deisch; Jack Raisanen; Dinesh Rakheja
Journal:  Pathol Oncol Res       Date:  2011-01-22       Impact factor: 3.201

5.  Synergistic cooperation of Sall4 and Cyclin D1 in transcriptional repression.

Authors:  Johann Böhm; Frank J Kaiser; Wiktor Borozdin; Reinhard Depping; Jürgen Kohlhase
Journal:  Biochem Biophys Res Commun       Date:  2007-03-19       Impact factor: 3.575

6.  A SALL4 zinc finger missense mutation predicted to result in increased DNA binding affinity is associated with cranial midline defects and mild features of Okihiro syndrome.

Authors:  Jan Miertus; Wiktor Borozdin; Vladimir Frecer; Giorgio Tonini; Sara Bertok; Antonio Amoroso; Stanislav Miertus; Jürgen Kohlhase
Journal:  Hum Genet       Date:  2006-01-03       Impact factor: 4.132

7.  Exome sequencing in developmental eye disease leads to identification of causal variants in GJA8, CRYGC, PAX6 and CYP1B1.

Authors:  Ivan Prokudin; Cas Simons; John R Grigg; Rebecca Storen; Vikrant Kumar; Zai Y Phua; James Smith; Maree Flaherty; Sonia Davila; Robyn V Jamieson
Journal:  Eur J Hum Genet       Date:  2013-11-27       Impact factor: 4.246

8.  Duane radial ray syndrome (Okihiro syndrome) maps to 20q13 and results from mutations in SALL4, a new member of the SAL family.

Authors:  Raidah Al-Baradie; Koki Yamada; Cynthia St Hilaire; Wai-Man Chan; Caroline Andrews; Nathalie McIntosh; Motoi Nakano; E Jean Martonyi; William R Raymond; Sada Okumura; Michael M Okihiro; Elizabeth C Engle
Journal:  Am J Hum Genet       Date:  2002-10-22       Impact factor: 11.025

9.  Elevating the levels of Sox2 in embryonal carcinoma cells and embryonic stem cells inhibits the expression of Sox2:Oct-3/4 target genes.

Authors:  Brian Boer; Janel Kopp; Sunil Mallanna; Michelle Desler; Harini Chakravarthy; Phillip J Wilder; Cory Bernadt; Angie Rizzino
Journal:  Nucleic Acids Res       Date:  2007-02-25       Impact factor: 16.971

10.  Association of a de novo 16q copy number variant with a phenotype that overlaps with Lenz microphthalmia and Townes-Brocks syndromes.

Authors:  Tanya M Bardakjian; Adele S Schneider; David Ng; Jennifer J Johnston; Leslie G Biesecker
Journal:  BMC Med Genet       Date:  2009-12-16       Impact factor: 2.103

View more
  4 in total

1.  CUGC for syndromic microphthalmia including next-generation sequencing-based approaches.

Authors:  Jonathan Eintracht; Marta Corton; David FitzPatrick; Mariya Moosajee
Journal:  Eur J Hum Genet       Date:  2020-01-02       Impact factor: 4.246

2.  Genetic disruption of zebrafish mab21l1 reveals a conserved role in eye development and affected pathways.

Authors:  Sarah E Seese; Brett Deml; Sanaa Muheisen; Elena Sorokina; Elena V Semina
Journal:  Dev Dyn       Date:  2021-03-12       Impact factor: 2.842

Review 3.  The Molecular Basis of Human Anophthalmia and Microphthalmia.

Authors:  Philippa Harding; Mariya Moosajee
Journal:  J Dev Biol       Date:  2019-08-14

4.  Confirming and expanding the phenotypes of FZD5 variants: Coloboma, inferior chorioretinal hypoplasia, and high myopia.

Authors:  Yi Jiang; Jiamin Ouyang; Shiqiang Li; Xueshan Xiao; Wenmin Sun; Qingjiong Zhang
Journal:  Mol Vis       Date:  2021-01-20       Impact factor: 2.367

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.